Navigation Links
Michael Epstein joins MedSpan Research as Director, Research Services
Date:11/1/2012

SOUTH BARRINGTON, Ill., Nov. 1, 2012 /PRNewswire-iReach/ -- MedSpan Research is pleased to announce its recent hire of Michael Epstein, who joins the company as Director, Research Services.  Mr. Epstein has taken a leadership role at MedSpan Research, managing execution of the company's research and consulting services.  Mr. Epstein has opened MedSpan Research's second office, which is in Rochester, NY.

"I was attracted to MedSpan Research's reputation, immediate access to key decision-makers, and growing client base.  Most of all, though, I was attracted by MedSpan Research's tight foci on third-party payers and healthcare technologies used in the hospital setting and alternative sites of care.  Manufacturers deserve mile-deep expertise from consultants.  That's exactly what MedSpan has on offer and I'm excited to become a part it." 

Mr. Epstein comes to MedSpan Research with 13 years of experience in the healthcare arena.  Most recently, Mr. Epstein was Director of Commercial Strategy and Reimbursement at United BioSource Corporation, a wholly owned subsidiary of Express Scripts.  At UBC Mr. Epstein led strategic engagements across the globe on behalf of many life sciences manufacturers.  Previously, Mr. Epstein also led primary market research engagements in the life sciences at Roger Green + Associates, TVG Marketing Research and Consulting, and Harris Interactive, and he evaluated behavioral health interventions at University of Rochester's Children's Institute.

Robert Kaminsky, founder and President of MedSpan Research, said, "I worked with Mike for four years before he joined MedSpan Research.  I've been impressed with his inquisitive mind and keen insight.  He is an expert in the markets MedSpan Research focuses on for our clients: managed care, hospitals and alternate sites of care.  Through thoughtful application of his expertise, Mike adds value to his client's marketing initiatives." 

Mr. Epstein attended University of Rochester, where he earned a BA magna cum laude and MA in political science, an MS in public policy analysis, and was also a PhD candidate in political science.

For more information, please contact Pam Kaminsky at 847-713-8083, pkaminsky@medspanresearch.com or visit the MedSpan Research website at  www.medspanresearch.com.

MedSpan Research is a healthcare market research company that provides primary qualitative and quantitative research for healthcare manufacturers and distributors. MedSpan offers clients the knowledge, experience and cutting-edge methodologies to address the marketing challenges many healthcare stakeholders face in today's complex and changing healthcare markets.

With MedSpan Research as their market research partner, manufacturers of drugs, medical devices, diagnostics, and diagnostic imaging equipment launch products and services with increased assurance that they will be adopted by physicians and other providers, valued by patients and caregivers, and reimbursed by payers.  MedSpan's client roster includes GE Healthcare, Grifols, Baxter Healthcare, Sagent Pharmaceuticals, Walgreens, McKesson and many more.

Media Contact: Michael Epstein of MedSpan Research, 224-234-4545, mepstein@medspanresearch.com

Media Contact: Robert Kaminsky MedSpan Research, 847.713.8080, RKaminsky@MedSpanResearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MedSpan Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
2. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
3. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
4. Response to U.S. Supreme Courts Healthcare Decision by Michael Zamagias, Chairman, TeleTracking Technologies
5. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
6. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
7. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
8. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
9. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
10. Financier Jeffrey Epstein And Mount Sinai Hospital Support 3D Mammograms For Breast Cancer
11. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... Aliso Viejo, California (PRWEB) , ... June 27, 2016 , ... ... that are fully customizable inside of Final Cut Pro X," said Christina Austin - ... with another unique style. Final Cut Pro X users can now reveal ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):